Price T Rowe Associates Inc Astrazeneca PLC Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Price T Rowe Associates Inc holds 51,942,963 shares of AZN stock, worth $3.91 Billion. This represents 0.41% of its overall portfolio holdings.

Number of Shares

51,942,963

Previous 57,086,881 9.01%

Holding current value

$3.91 Billion

Previous $4.2 Billion 13.49%

% of portfolio

0.41%

Previous 0.52%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$64.87 - $75.0 $334 Million - $386 Million	-5,143,918 Reduced 9.01%	51,942,963 $3.63 Billion
Q1 2025 May 14, 2025	SELL	$65.37 - $77.96 $213 Million - $255 Million	-3,265,092 Reduced 5.41%	57,086,881 $4.2 Billion
Q4 2024 Feb 14, 2025	SELL	$63.2 - $79.58 $161 Million - $202 Million	-2,540,609 Reduced 4.04%	60,351,973 $3.95 Billion
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $157 Million - $179 Million	-2,047,079 Reduced 3.15%	62,892,582 $4.9 Billion
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $245 Million - $296 Million	3,667,687 Added 5.99%	64,939,661 $5.06 Billion
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $549 Million - $626 Million	9,002,450 Added 17.22%	61,271,974 $4.15 Billion
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $91.3 Million - $102 Million	-1,475,163 Reduced 2.74%	52,269,524 $3.52 Billion
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $58.3 Million - $64.5 Million	899,089 Added 1.7%	53,744,687 $3.64 Billion
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $418 Million - $453 Million	-5,972,371 Reduced 10.15%	52,845,598 $3.78 Billion
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $617 Million - $700 Million	-9,773,679 Reduced 14.25%	58,817,969 $4.08 Billion
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $368 Million - $479 Million	-6,793,368 Reduced 9.01%	68,591,648 $4.65 Billion
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $559 Million - $1.43 Billion	-10,534,780 Reduced 12.26%	75,385,016 $4.14 Billion
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $492 Million - $591 Million	-8,310,073 Reduced 8.82%	85,919,796 $5.68 Billion
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $245 Million - $295 Million	4,389,118 Added 4.89%	94,229,869 $6.25 Billion
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $406 Million - $480 Million	7,518,229 Added 9.13%	89,840,751 $5.23 Billion
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $798 Million - $874 Million	14,370,118 Added 21.15%	82,322,522 $4.94 Billion
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $480 Million - $596 Million	9,905,274 Added 17.06%	67,952,404 $4.07 Billion
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $1.86 Billion - $2.15 Billion	39,450,439 Added 212.14%	58,047,130 $2.89 Billion
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $902 Million - $1.08 Billion	18,596,691 New	18,596,691 $930 Million

Others Institutions Holding AZN

# of Institutions

1,412

Shares Held

499M

Call Options Held

7.11M

Put Options Held

2.56M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Astrazeneca PLC Transaction History